Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saturn-1: TP-03 for Demodex Blepharitis
NCT04475432Phase 3Completed
- Sponsor
- Tarsus Pharmaceuticals, Inc.
- Start
- Sep 2020
- Primary completion
- May 2021
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lotilaner in Demodex blepharitis (DB), sponsored by Tarsus Pharmaceuticals, Inc.. Started Sep 2020; status: completed.
02
Drugs
lotilaner
03
Conditions
Demodex blepharitis (DB)
Beyond the preview
Go deeper on NCT04475432.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04475432.